Interpace Biosciences Inc. (IDXG): The rub is I don't think retail can shor...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Interpace Biosciences Inc. (IDXG)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	67
Posts	3539
Boards Moderated	0
Alias Born	04/25/2010

Re: rpablo23 post# 1631

Friday, 01/20/2017 1:20:34 PM

Friday, January 20, 2017 1:20:34 PM

The rub is I don't think retail can short it, big boys have all those shares, and then some...they will continue to naked short this...but into oblivion this time around...game is fixed...plus retail has been screwed too many times with these continuous offerings...not a good combo

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent IDXG News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:01:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:33:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:05:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:14:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:16:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:05:18 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/22/2023 08:53:38 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/22/2023 08:20:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 07:47:52 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 05:27:44 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 09:24:47 PM

More IDXG News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow